Original Research
Published on 09 Aug 2024
Adverse event reporting of the IGF-1R monoclonal antibody teprotumumab: a real-world study based on the US food and drug administration adverse event reporting system
in Drugs Outcomes Research and Policies
- 4,082 views
- 7 citations